Comparative Effectiveness and Safety of Different Types of Inhaled Long-Acting β2-Agonist Plus Inhaled Long-Acting Muscarinic Antagonist vs Inhaled Long-Acting β2-Agonist Plus Inhaled Corticosteroid Fixed-Dose Combinations in COPD A Propensity Score-Inverse Probability of Treatment Weighting Cohort Study

Despite multiple available fixed-dose combinations (FDCs) of inhaled long-acting β2-agonists (LABAs) plus long-acting muscarinic antagonists (LAMAs) and LABAs plus inhaled corticosteroids (ICS) for COPD, uncertainty remains regarding their comparative effects. Can comparative effectiveness and safet...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Chest 2021-10, Vol.160 (4), p.1255-1270
Hauptverfasser:	Wang, Meng-Ting, Lai, Jyun-Heng, Huang, Ya-Ling, Liou, Jun-Ting, Cheng, Shih-Hsuan, Lin, Chen Wei, Pan, Hsueh-Yi, Hsu, Yu-Juei, Tsai, Chen-Liang
Format:	Artikel
Sprache:	eng
Schlagworte:	comparative effectiveness COPD COPD exacerbation dual therapies observational study
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!